We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
+9.2%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$3.36B
AUM Growth
-$521M
Cap. Flow
-$561M
Cap. Flow %
-16.68%
Top 10 Hldgs %
31.32%
Holding
2,193
New
694
Increased
377
Reduced
430
Closed
579
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PUCKW
1576
DELISTED
Goal Acquisitions Corp. Warrant
PUCKW
$10K ﹤0.01%
+15,400
New +$8.42K
CRXTW
1577
DELISTED
Clarus Therapeutics Holdings, Inc. Warrants
CRXTW
$10K ﹤0.01%
+13,273
New +$8.32K
BREZW
1578
DELISTED
Breeze Holdings Acquisition Corp. Warrant
BREZW
$9K ﹤0.01%
+12,889
New +$8.08K
ACBAW
1579
DELISTED
Ace Global Business Acquisition Ltd Warrant
ACBAW
$9K ﹤0.01%
+18,995
New +$9.58K
ATA.WS
1580
DELISTED
Americas Technology Acquisition Corp.Redeemable Warrants, each whole warrant exercisable for one Ordinary Share at an exercise price of $11.50
ATA.WS
$9K ﹤0.01%
13,961
+796
+6% +$453
SLCRW
1581
DELISTED
Silver Crest Acquisition Corporation Warrant
SLCRW
$9K ﹤0.01%
+10,923
New +$6.64K
ASPCW
1582
DELISTED
Alpha Capital Acquisition Co Warrant
ASPCW
$9K ﹤0.01%
+11,230
New +$7.04K
COEPW
1583
DELISTED
Coeptis Therapeutics Warrants
COEPW
$8K ﹤0.01%
+15,000
New +$7.63K
PMGMW
1584
DELISTED
Priveterra Acquisition Corp. II Warrant to purchase Class A common stock
PMGMW
$8K ﹤0.01%
+10,840
New +$7.6K
ALTIW
1585
DELISTED
AlTi Global Inc Warrant
ALTIW
$8K ﹤0.01%
+10,000
New +$6.83K
ESSCW
1586
DELISTED
East Stone Acquisition Corporation Warrant
ESSCW
$8K ﹤0.01%
28,592
+9,342
+49% +$2.32K
ONMDW icon
1587
OneMedNet Corp Warrant
ONMDW
$7K ﹤0.01%
+15,000
New +$7.46K
VENAW
1588
DELISTED
Venus Acquisition Corporation Warrant
VENAW
$6K ﹤0.01%
+17,902
New +$6.04K
QFTA.WS
1589
DELISTED
Quantum FinTech Acquisition Corporation Warrants, each warrant exercisable for one-half of one share of Common Stock at an exercise price of $11.50
QFTA.WS
$6K ﹤0.01%
19,488
+4,161
+27% +$1.26K
ALACW
1590
DELISTED
Alberton Acquisition Corp Warrant
ALACW
$6K ﹤0.01%
+13,987
New +$5.27K
VHAQ.RT
1591
DELISTED
Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock
VHAQ.RT
$4K ﹤0.01%
+14,057
New +$2.9K
A icon
1592
Agilent Technologies
A
$41.2B
-5,520
Closed -$702K
ABEO icon
1593
Abeona Therapeutics
ABEO
$413M
-1,180
Closed -$55K
ABR icon
1594
Arbor Realty Trust
ABR
$998M
-33,450
Closed -$532K
ABR icon
1595
PUT
Arbor Realty Trust
ABR
$998M
-155,000
Closed -$2.46M
ACM icon
1596
Aecom
ACM
$9.75B
-4,060
Closed -$260K
ACTG icon
1597
Acacia Research
ACTG
$470M
-191,500
Closed -$1.27M
ADPT icon
1598
PUT
Adaptive Biotechnologies
ADPT
$3.97B
-20,000
Closed -$805K
ADV icon
1599
Advantage Solutions
ADV
$361M
-529
Closed -$156K
AEM icon
1600
PUT
Agnico Eagle Mines
AEM
$90.5B
-50,000
Closed -$2.89M

Similar funds

Prelude Capital Management's Q2 2021 Portfolio in Review

As of Q2 2021, Prelude Capital Management held 2,193 positions worth $3.36B, down 13% from $3.89B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Prelude Capital Management withdrew a net $561M in Q2 2021, closing 579 positions and reducing 430 holdings. Its most notable exit was iShares iBoxx $ High Yield Corporate Bond ETF, an estimated $39.4M position sold in full.

By sector, the portfolio is most concentrated in Technology at 9% of assets, up from 6.6% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Prelude Capital Management opened a new position in KKR Acquisition Holdings I Corp. worth $36.3M.

  • Prelude Capital Management's largest Q2 2021 buy was KKR Acquisition Holdings I Corp.: 3,700,000 shares worth $36.3M.
  • Prelude Capital Management added most to PRA Health Sciences, Inc. in Q2 2021, an estimated $19.4M increase.
  • Prelude Capital Management's biggest Q2 2021 reduction was Micron Technology, cutting an estimated $7.72M.
  • Prelude Capital Management fully exited iShares iBoxx $ High Yield Corporate Bond ETF in Q2 2021, selling an estimated $39.4M.
  • Prelude Capital Management's ten largest holdings make up 31% of its $3.36B portfolio in Q2 2021.
  • Prelude Capital Management opened 694 new positions and closed 579 in Q2 2021.
  • Prelude Capital Management's portfolio value fell 13% quarter-over-quarter to $3.36B.

Based on Prelude Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.